grant

Cell-free DNA epigenomics to track the dynamics of organ damage and immune exhaustion during sepsis

Organization MAYO CLINIC ROCHESTERLocation ROCHESTER, UNITED STATESPosted 1 Sept 2021Deadline 30 Jun 2026
NIHUS FederalResearch GrantFY2025BioinformaticsBloodBlood Plasma CellBlood Reticuloendothelial SystemBlood SampleBlood specimenBody TissuesCause of DeathCell BodyCellsCessation of lifeDNA analysisDNA methylation profilingDataDeathDiseaseDisorderImmuneImmunesIntensive Care UnitsKineticsLiteratureMOF syndromeMediatingMethodologyMethodsMethyl-SeqMethylSeqMethylation sequencingMorbidityMorbidity - disease rateMultiple Organ Dysfunction SyndromeMultiple Organ FailureOrganOutcomePatient AdmissionPatientsPlasma CellsPlasmacytesProcessResearchSepsisSourceState HospitalsT-CellsT-LymphocyteTissuesUnited StatesWorkanalyze DNAcell free DNAcell free circulating DNAepigenomicsexhaustexhaustiongenome wide methylationgenomewide methylationglobal methylationimprovedinnovateinnovationinnovativemortalitymultiorgan failuremultiple organ system failureplasmocyteprogramssecondary infectionthymus derived lymphocyte
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Sepsis is the most frequent cause of death in United States hospitals, and the number one cause of

death worldwide, responsible for 11 million deaths in 2017. Primary drivers of sepsis morbidity and

mortality are immune exhaustion leading to deadly secondary infection, and organ tissue damage

leading to multi-organ failure. Despite the critical importance of these processes in governing ultimate

sepsis outcomes, we have an incomplete understanding of their kinetics and dynamics. We thus

propose a two-pronged effort to shift our paradigm regarding sepsis dynamics through plasma cell-free

DNA analysis. Specifically, we propose to 1) track the dynamics of organ-specific damage, and 2) track

the dynamics of T cell exhaustion during sepsis. We will do this through analysis of daily blood samples

acquired from patients admitted to the intensive care unit for sepsis. Methodologically, we will achieve

these through genome-wide methylation sequencing of cell-free DNA. Bioinformatically, we will then

perform CIBERSORTx deconvolution to delineate and quantify specific cell/tissue types contributing to

plasma cell-free DNA, thus enabling us to infer organ tissues being damaged as well as T cell

exhaustion levels from both blood and tissue sources. The methods we will utilize here are highly

innovative yet feasible given recent literature and our own preliminary data. Our proposed work will

form the basis for a rich sepsis-focused research program utilizing cell-free DNA analysis to

answer major questions in the field with the potential to ultimately improve patient survival for

the deadliest disease worldwide.

Grant Number: 5R35GM142710-06
NIH Institute/Center: NIH

Principal Investigator: Aadel Chaudhuri

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →